MedPath

A pilot study of delineation of the horizontal extent of gastric cancer by Helicobacter pylori eradication or non-eradication.

Not Applicable
Conditions
gastric cancer
Registration Number
JPRN-UMIN000016700
Lead Sponsor
Ishikawa prefectural central hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

(a)Patients who had undergone gastrectomy. (b)Patients in whom a gastric cancer is located in the junction of the esophagus and the stomach. (c)At the time of registration, HP-negative patients who have not had HP eradication. (d)At the time of registration, HP-negative patients in whom HP eradication is unidentified. (e)Patients who do not give informed consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of the delineation of the gastric cancer according to HP eradication or non-eradication that we able to diagnose exactly.
Secondary Outcome Measures
NameTimeMethod
The proportion of the delineation of the gastric cancer according to a period of HP eradication that we were able to diagnose exactly. Frequency of the metachronous gastric cancers according to HP eradication or non-eradication. The proportion of the gastric cancer that fullfill tumor indication for endoscopic resection of Japanese gastric cancer treatment guidelines 2010 in semiannual surveillance after ESD. In addition, we will conduct exploratory and comprehensive analyses.
© Copyright 2025. All Rights Reserved by MedPath